Literature DB >> 4050618

Neurotensin-like immunoreactivity in some preparations of secretin and cholecystokinin.

G E Feurle.   

Abstract

Commercially available cholecystokinin (CCK) from the Boots Company, Nottingham and to a lesser degree CCK from the Gastrointestinal Hormone Research Unit of Karolinska Institute Stockholm and from Kabi Diagnostica, Studsvik, and also secretin from the Boots Company have been found to contain neurotensin-like immunoreactive contamination. As neurotensin is able to stimulate pancreatic secretion, this admixture may be of relevance when pancreatic function is tested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4050618     DOI: 10.1007/BF01982882

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  The physiology of secretin.

Authors:  M I GROSSMAN
Journal:  Vitam Horm       Date:  1958       Impact factor: 3.421

Review 2.  Secretin: a long progress note.

Authors:  K A Hubel
Journal:  Gastroenterology       Date:  1972-02       Impact factor: 22.682

3.  Effect of neurotensin on exocrine pancreatic secretion in dogs.

Authors:  I Baca; G E Feurle; A Schwab; U Mittmann; W Knauf; T Lehnert
Journal:  Digestion       Date:  1982       Impact factor: 3.216

4.  Effect of neurotensin on pancreatic function in man.

Authors:  D R Fletcher; A M Blackburn; T E Adrian; V S Chadwick; S R Bloom
Journal:  Life Sci       Date:  1981-11-23       Impact factor: 5.037

5.  Pure cholecystokinin: pancreatic protein and bicarbonate response.

Authors:  H T Debas; M I Grossman
Journal:  Digestion       Date:  1973       Impact factor: 3.216

6.  Comparison of the biological potency of a new synthetic preparation of secretin with that of natural porcine secretin in the dog.

Authors:  K Gyr; L Kayasseh; W W Rittmann; J Girard; G A Stalder
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

7.  Interaction of neurotensin, cholecystokinin, and secretin in the stimulation of the exocrine pancreas in the dog.

Authors:  I Baća; G E Feurle; M Haas; T Mernitz
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.